BGB Group

Last week, here on LinkedIn, you met Juan M. Valdez Capuccino, Ph.D. as he walked the halls of the annual Alzheimer's Association International Conference in Philly as one of BGB Group's distinguished neurology experts. Today, in partnership with Exene Anderson, PhD and our Kx Advisors colleagues Chris Waybill, Adriana González-Caballero, and Chloe Weiser, Juan is digging a bit deeper into one of the topics that came up - blood biomarkers in Alzheimer's Disease diagnosis. Did you know the average predicted wait time between clinical diagnosis and treatment of AD is 18.6 months? We invite you to learn more about the different types of BBMs and how they may evolve patient diagnosis of AD and the treatment journey. Read more about this topic in the link below: https://go.bgbx.ai/BBBM

Our BGB Group colleagues Juan M. Valdez Capuccino, Ph.D., Gina Marrone PhD Susan Duffy, and Kx Advisors partners Nikil D. Kumar and Chris Waybill spent the last week in Philly at the Alzheimer's Association International Conference taking in the latest data on diagnosis, treatment, and disease management. In such a complex space, it's topics like emerging targets and how blood based biomarkers will inform treatment decisions that have our experts excited. We'll share more on these topics in the coming days. Reach out to learn more about what we took away from AAIC and our perspective on the future of AD!

We're INSPIRED!!! The BGB Group team had the pleasure of hosting Motif Neurotech in NYC yesterday, where we talked about the topic of mental illness today and the united vision we have for tomorrow. We're thankful for the opportunity to partner with such wonderful leaders...brilliant, innovative, caring...the future is bright!!

We are ALWAYS looking for ways to elevate the work we do for our clients. Last week, we dipped into the world of design... Brian Keys, Jerlyn O., and Jacob Molloy had the exciting opportunity to explore what the future of design looks like at Figma Config and Adobe Make It. We observed new features and a suite of AI-powered tools that promise to offer more streamlined experiences, revolutionize our design workflow, and enhance our collaboration. We're excited to continue to explore possibilities and integrate new ways of working into our every day. #designexperts #futurefocused #creativetransformation

#LoveisLove This PRIDE month, we're celebrating LGBTQ+ excellence in medicine! Check out our video highlighting influential LGBTQ+ professionals who have shaped medical history and championed inclusion in healthcare. Learn why Dr. Alan Hart, Dr. Magnus Hirschfeld, Dr. Rachel Levine, Peter Stanley, Dr. Michael Gottlieb, and Dr. Linda Laubenstein inspire us. We celebrate inclusion this month and every month. It's in our DNA! #bgbyourself #bgbproud

Last week, our BGBers Angela Nurse and Gina Lee Barrientos, PharmD, RPh attended the Black in Cancer Conference which drew world renowned speakers, students, clinicians, researchers, and industry leaders. The organization works hard to build support networks increasing the number of black cancer researchers, facilitates mentorship and collaborations for student scientists, and gives cancer survivors and patient advocates a platform to share their experiences and insights. Our team noted they felt the excitement, eagerness, and motivation from all attendees from the minute they walked in. We are very proud to have sponsored an event with such a powerful mission and theme of “Lifting as We Climb” which emphasized the critical role we ALL play in creating sustainable pathways for future black cancer pioneers.

We have BIG news… BGB has launched into a new era of transformational boundary-pushing and a commitment to delivering elite creative thinking. Leading us in this charge, we are SO THRILLED to welcome Chris Palmer as our first-ever Chief Creative Officer! Chris is a legend, and we are incredibly excited for his unique creative approach and propensity for innovation to impact our clients’ business. Last week, Chris sat down with MM+M to talk about accelerating the growth of our agency's creative capabilities and modernizing our approach to pharma commercialization. In this discussion, Chris highlights his eagerness to work alongside our Innovation and Intelligence division, integrating Al-based solutions to not only create, but also to personalize and deploy optimized content. We're now ready to push creative ideation even further, and look forward to evaluating our work through the lens that Chris uses - Are we making the world a better, more beautiful place for the physicians and patients who need us? Read more here: https://lnkd.in/eXq8w__v

The value of real-world evidence has been on everyone's mind now more than ever! Eleanor (Tyler) Maughan, PhD talks to us about how we can better leverage RWE to drive innovation in early research, clinical trials, regulatory approvals, commercialization and post-market surveillance. Read more here: https://rb.gy/yuboa0

Have you checked out MM+M's 2024 Agency 100 list? We're so thrilled for another year as a top 25 agency in the country!! This year, the much anticipated creative exercise called for the design of a sports jersey... BGB has the brains. And we bring a storm of creative and strategic innovation. Thriving on the electricity of cutting-edge thinking, every day we change the game for our clients... Check out our profile here: https://lnkd.in/ep_c2hhH

Were you at the American Society of Clinical Oncology (ASCO) plenary yesterday afternoon? SO much applause!!! Our VP, Medical Director Denise (Minton) Lee-Thorp doubles as a professional news anchor and tuned us in to the data she found most exciting... Reach out to us to learn more about how we anticipate these key data will translate into clinical practice. #thatsawrap #ASCO #oncexperts